ETNB
Price
$8.11
Change
+$0.41 (+5.32%)
Updated
May 12 closing price
Capitalization
1.12B
86 days until earnings call
SGMT
Price
$3.31
Change
+$0.05 (+1.53%)
Updated
May 12 closing price
Capitalization
104.96M
Ad is loading...

ETNB vs SGMT

Header iconETNB vs SGMT Comparison
Open Charts ETNB vs SGMTBanner chart's image
89bio
Price$8.11
Change+$0.41 (+5.32%)
Volume$1.33M
Capitalization1.12B
Sagimet Biosciences
Price$3.31
Change+$0.05 (+1.53%)
Volume$538.2K
Capitalization104.96M
ETNB vs SGMT Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. SGMT commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Buy and SGMT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (ETNB: $8.11 vs. SGMT: $3.31)
Brand notoriety: ETNB and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 67% vs. SGMT: 101%
Market capitalization -- ETNB: $1.12B vs. SGMT: $104.96M
ETNB [@Biotechnology] is valued at $1.12B. SGMT’s [@Biotechnology] market capitalization is $104.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ETNB and SGMT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 6 TA indicator(s) are bullish while SGMT’s TA Score has 7 bullish TA indicator(s).

  • ETNB’s TA Score: 6 bullish, 5 bearish.
  • SGMT’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а -5.81% price change this week, while SGMT (@Biotechnology) price change was -7.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ETNB is expected to report earnings on Aug 07, 2025.

SGMT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-3.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.12B) has a higher market cap than SGMT($105M). ETNB YTD gains are higher at: 3.708 vs. SGMT (-26.444). SGMT has higher annual earnings (EBITDA): -65.55M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. SGMT (145M). SGMT has less debt than ETNB: SGMT (39K) vs ETNB (37.6M). ETNB (0) and SGMT (0) have equivalent revenues.
ETNBSGMTETNB / SGMT
Capitalization1.12B105M1,070%
EBITDA-380.21M-65.55M580%
Gain YTD3.708-26.444-14%
P/E RatioN/AN/A-
Revenue00-
Total Cash639M145M441%
Total Debt37.6M39K96,410%
TECHNICAL ANALYSIS
Technical Analysis
ETNBSGMT
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMCX7.310.26
+3.69%
Royce Micro-Cap Consult
UGTCX26.75N/A
N/A
Victory Growth and Tax Strategy C
TIOIX15.40N/A
N/A
Nuveen International Opps R6
VLSAX16.86N/A
N/A
Virtus KAR Long/Short Equity A
CVSOX15.23N/A
N/A
Calamos Market Neutral Income R6

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+5.32%
AKRO - ETNB
60%
Loosely correlated
+4.22%
RCKT - ETNB
57%
Loosely correlated
+0.14%
IDYA - ETNB
55%
Loosely correlated
+5.34%
NTLA - ETNB
52%
Loosely correlated
+5.30%
COGT - ETNB
52%
Loosely correlated
+6.65%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with CCCC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+1.53%
CCCC - SGMT
42%
Loosely correlated
+7.48%
VRDN - SGMT
40%
Loosely correlated
+5.89%
ETNB - SGMT
40%
Loosely correlated
+5.32%
CRBU - SGMT
39%
Loosely correlated
+5.66%
TERN - SGMT
39%
Loosely correlated
-0.66%
More